Liraglutide Liraglutide is a GLP-1 receptor agonist like semaglutide that helps control blood sugar and aids in weight loss in overweight or obese people
Ginkgo Bioworks Sector: Biotechnology and synthetic biology HQ: The Innovation and Design Building at 27 Drydock Ave, Boston, MA Year Founded: 2008 Key Leaders: Jason Kelly, Co-Founder and CEO Number of Employees: 800900 Stage: Public Financial Snapshot: $709.80 million market cap Notable Investors: Viking Global Investors, General Atlantic, and Cascade Investment Key Products: Ginkgo Bioworks operates a cell programming platform that engineers microbes and cells to produce pharmaceuticals and other products, such as chemicals and food ingredients
244 In animal models, it reduces hepatic steatosis, lowers serum ALT and AST levels, and increases mitochondrial respiration and adenosine triphosphate production efficiency
In 2021, the results of a meta-analysis that included 7 RCT studies showed that GLP-RA uses resulted in a decreased risk of respiratory disease [43]
Collagen is the structural protein responsible for skin elasticity, firmness, and hydration